Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma.
Wang H, Li YX, Wang WH, Jin J, Dai JR, Wang SL, Liu YP, Song YW, Wang ZY, Liu QF, Fang H, Qi SN, Liu XF, Yu ZH. Wang H, et al. Among authors: jin j. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1115-21. doi: 10.1016/j.ijrobp.2011.02.039. Epub 2011 Apr 20. Int J Radiat Oncol Biol Phys. 2012. PMID: 21514070
Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN, Li YX, Wu RY, Zhang XM, Wang WH, Jin J, Song YW, Fang H, Ren H, Wang SL, Liu YP, Liu XF, Chen B, Dai JR, Yu ZH. Lu NN, et al. Among authors: jin j. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):210-6. doi: 10.1016/j.ijrobp.2011.11.008. Epub 2012 Mar 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22436783
Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.
Xu LM, Li YX, Fang H, Jin J, Wang WH, Wang SL, Liu YP, Song YW, Liu QF, Chen B, Qi SN, Ren H, Dai JR. Xu LM, et al. Among authors: jin j. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1289-95. doi: 10.1016/j.ijrobp.2012.10.037. Epub 2012 Dec 11. Int J Radiat Oncol Biol Phys. 2013. PMID: 23245279
Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang X, Tian Y, Tang Y, Hu ZH, Zhang JJ, Fu GS, Ma P, Ren H, Zhang T, Li N, Liu WY, Fang H, Li YX, Jin J. Wang X, et al. Among authors: jin j. Oncotarget. 2017 Jun 13;8(24):39727-39735. doi: 10.18632/oncotarget.14459. Oncotarget. 2017. PMID: 28061474 Free PMC article.
Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
Wang J, Song Y, Liu X, Jin J, Wang W, Yu Z, Liu Y, Li N, Fang H, Ren H, Tang Y, Tang Y, Chen B, Lu N, Qi S, Wang S, Li Y. Wang J, et al. Among authors: jin j. Cancer Med. 2019 Mar;8(3):902-909. doi: 10.1002/cam4.1919. Epub 2019 Feb 10. Cancer Med. 2019. PMID: 30740916 Free PMC article.
13,267 results
You have reached the last available page of results. Please see the User Guide for more information.